Interaction of butene with human hemoglobin A.

The role of hydrocarbons in modulating hemoglobin function remains poorly understood. Prior research has shown that certain alkanes can bind to proteins, but specific mechanisms remain unclear. No prior work had resolved how butene might influence oxygen binding. This gap motivated investigation into butene's effects on hemoglobin. The study aimed to clarify whether butene alters hemoglobin's oxygen affinity. Allosteric effects are known in hemoglobin, but hydrocarbon involvement is less established. This paper explores butene's potential as an allosteric effector. The findings may contribute to understanding gas transport regulation.

This study aimed to determine how butene affects hemoglobin's oxygen-binding properties. The researchers focused on whether butene alters oxygen affinity without changing cooperativity. They tested the effect under various pH and ionic strength conditions. The goal was to identify if butene acts as an allosteric modulator. Mathematical modeling was used to estimate binding constants. The study also sought to locate the binding site on hemoglobin. The researchers hypothesized that butene interacts through hydrophobic regions. Their findings could clarify how nonpolar molecules influence hemoglobin function.

The study used human hemoglobin under controlled pressure and pH conditions. Butene was introduced at 1 atm to observe oxygen affinity changes. Researchers measured p50 values to assess oxygen binding. Mathematical simulations were applied to model binding curves. Association constants were calculated for Hb and HbO2. The first oxygen association constant K1 was also analyzed. Experiments varied butene concentration to test saturation effects. Results were compared across pH and ionic strength levels.

Butene reduced hemoglobin's oxygen affinity by 45% at 1 atm. This effect occurred without altering ligand cooperativity. The change was consistent across pH 7.0 to 8.0. Association constants were calculated as 10.4 and 1.53 mmol-1. Butene binding was stronger to deoxygenated hemoglobin. K1 decreased by 25%, indicating altered oxygen binding. The binding site may be at the alpha 1 beta 2 interface. These findings suggest butene acts as an allosteric effector.

The authors propose that butene functions as an allosteric effector of hemoglobin. They suggest that butene's effect is likely due to hydrophobic interactions. The binding site is hypothesized to be at the alpha 1 beta 2 interface. The study shows that butene reduces oxygen affinity without affecting cooperativity. Mathematical models support a single binding site mechanism. The effect was consistent across pH and ionic strength changes. These findings may inform future studies on hemoglobin modulation. The authors suggest further investigation into hydrocarbon interactions.